Status:
UNKNOWN
poSt Covid-19 Infection centraL Sensitisation 2
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate whether there are indicators of central sensitisation in patients post covid-19 infection.
Detailed Description
The COVID-19 pandemic is currently a serious global public health concern. This disease is caused by a novel coronavirus which was first discovered in Wuhan, China in 2019 and later spread rapidly thr...
Eligibility Criteria
Inclusion
- Patients with a diagnosed covid-19 infection that took place 2-8 weeks before study inclusion.
- Cognitive and language functioning enabling coherent communication between the researcher and the participant.
- French-or Dutch speaking persons.
Exclusion
- Covid-19 infection \> 8 weeks ago.
Key Trial Info
Start Date :
January 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04701892
Start Date
January 19 2021
End Date
January 1 2023
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Brussel
Jette, Brussels Capital, Belgium, 1090